Related Experiment Video
Updated: Jun 23, 2026

A Genetically Engineered Mouse Model of Sporadic Colorectal Cancer
Published on: July 6, 2017
Somatic mutations of the CDC4 (FBXW7) gene in hereditary colorectal tumors
Michiko Miyaki1, Tatsuro Yamaguchi, Takeru Iijima
1Hereditary Tumor Research Project, Tokyo Metropolitan Komagome Hospital, Tokyo, Japan.
Objectives:
Cdc4 (Fbxw7) is a potential tumor suppressor that regulates ubiquitination and proteolysis of multiple targets such as cyclin E, c-Myc, c-Jun and Notch. CDC4 mutations were investigated in 194 colorectal carcinomas and adenomas for comparison between sporadic and hereditary cancers.
Methods:
Mutations of the CDC4 gene were analyzed by PCR-SSCP and sequencing, and loss of heterozygosity (LOH) was analyzed by microsatellite marker analysis.
Results:
Somatic CDC4 mutations were detected in 9% (3 of 33) of hereditary nonpolyposis colorectal cancer (HNPCC), 9% (3 of 33) of familial adenomatous polyposis (FAP) carcinomas, and 10% (7 of 73) of sporadic carcinomas. CDC4 mutations were also detected in adenomas at frequencies of 6% (2 of 31) and 4% (1 of 24) in FAP and sporadic cases, respectively. Frameshift mutations were observed in HNPCC tumors, while single-base substitutions predominantly occurred in FAP and sporadic tumors. LOH at the chromosome 4q region was rarely detected in tumors with CDC4 mutations.
Conclusions:
The results indicate that the frequency of CDC4 mutations in colorectal tumors is similar in patients with HNPCC and FAP compared to patients with sporadic carcinomas. Moreover, infrequent LOH suggests that the CDC4 gene does not follow the general 2-hit model.
Insights
CDC4 (Fbxw7) mutations are similarly frequent in hereditary and sporadic colorectal cancers. Infrequent loss of heterozygosity suggests CDC4 does not follow the typical two-hit tumor suppressor model.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Cdc4 (Fbxw7) functions as a tumor suppressor by regulating the ubiquitination and degradation of key proteins like cyclin E, c-Myc, c-Jun, and Notch.
- Investigating CDC4 mutations is crucial for understanding colorectal cancer development, particularly in distinguishing between sporadic and hereditary forms.
Purpose of the Study:
- To compare the frequency and types of CDC4 gene mutations in colorectal carcinomas and adenomas between sporadic and hereditary cancer cases.
- To assess the role of loss of heterozygosity (LOH) at the 4q region in tumors with CDC4 mutations.
Main Methods:
- Mutation analysis of the CDC4 gene was performed using Polymerase Chain Reaction-Single Strand Conformation Polymorphism (PCR-SSCP) and sequencing.
- Loss of heterozygosity (LOH) was analyzed using microsatellite marker analysis.
Main Results:
- Somatic CDC4 mutations were found in 9% of hereditary nonpolyposis colorectal cancer (HNPCC) and familial adenomatous polyposis (FAP) carcinomas, and 10% of sporadic carcinomas.
- Mutations were also detected in adenomas (6% FAP, 4% sporadic). Frameshift mutations were noted in HNPCC, while single-base substitutions predominated in FAP and sporadic tumors.
- Loss of heterozygosity (LOH) in the chromosome 4q region was infrequent in tumors harboring CDC4 mutations.
Conclusions:
- The frequency of CDC4 mutations in colorectal tumors is comparable across HNPCC, FAP, and sporadic cancer types.
- The low incidence of LOH suggests that the CDC4 gene may not operate under the conventional two-hit hypothesis for tumor suppression.
Related Concept Videos
Cancers Originate from Somatic Mutations in a Single Cell
Cancers Originate from Somatic Mutations in a Single Cell
Pleiotropy
Mutations
Renewal of Intestinal Stem Cells
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
